Healthcare professional having a discussion in clinic

ORION Observational Study

Toujeo® insulin glargine 300units/ml

There is an intense desire to participate in fasting during Ramadan, even among the people who could seek exemption1. Discover the ORION study and the 2021 IDF-DAR Practical guidance.

Summary

Download a summary of the ORION study. Real-world safety and effectiveness of Toujeo® in patients with Type 2 Diabetes who choose to fast during Ramadan.

Diabetes and Ramadan Practical Guidelines 2021

IDF-DAR Guidance

  • Updated set of criteria for risk stratification
  • Information on the impact of fasting on physical and mental well-being
  • Specific guidance on the management of T1 & T2 in special populations 
  • Information on changes to the risk of comorbidities

Full Publication

Read the full publication of the ORION observational study in patients with Type 2 Diabetes who choose to fast during Ramadan.

An old couple working on laptop

Patient Handbooks

Download a handbook to support your patients treated with Toujeo. It is available in English, Bengali, Punjabi and Urdu.

SOLOSTAR HANDBOOK

Lady talking on phone

Always up to date?

Webinars, evidence, expert video’s, peer-to-peer events… Do you want to be the first to know when new, relevant information is available? Let us know and we’ll send you a message.

References

1. Diabetes and Ramadan Practical Guidelines 2021. Available at: https://www.idf.org/our-activities/education/diabetes-and-ramadan/healthcare-professionals.html [Accessed: February 2021].
This site uses cookies to store information on your computer. Some cookies on this site are needed because the site won’t work as expected without them. To learn more about cookies, please read our Cookie Policy.
By closing this message or using the website, you agree to our use of cookies on this device in agreement with our Cookie Policy, unless you have turned them off.
Accept and close